LINSLEY PETER S 4
4 · AVI BIOPHARMA INC · Filed May 16, 2011
Insider Transaction Report
Form 4
LINSLEY PETER S
SVP & Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2011-05-16+800,000→ 800,000 totalExercise: $1.76Exp: 2021-05-16→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]This option is exercisable at the rate of 25% of the shares on May 1, 2012 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on May 1, 2015.